Semaglutide-Associated Acute Interstitial Nephritis: A Case Report

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are being investigated to slow the decline of kidney function in type 2 diabetics with chronic kidney disease (CKD). These agents have proven benefits on cardiac outcomes and all-cause mortality as well as in reducing the incidence of macroalbumin...

Descripción completa

Detalles Bibliográficos
Autores principales: Borkum, Megan, Lau, Wynnie, Blanco, Paula, Farah, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719074/
https://www.ncbi.nlm.nih.gov/pubmed/36471818
http://dx.doi.org/10.1016/j.xkme.2022.100561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719074/
https://www.ncbi.nlm.nih.gov/pubmed/36471818
http://dx.doi.org/10.1016/j.xkme.2022.100561

Ejemplares similares